VF
GPCR icon

Virtu Financial’s Structure Therapeutics GPCR Stock Holding History

Virtu Financial’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,779
Closed -$307K – 1709
2025
Q2 		$307K Buy
+14,779
New +$325K 0.02% 745
2024
Q3 		– Sell
-10,034
Closed -$394K – 1562
2024
Q2 		$394K Buy
10,034
+2,848
+40% +$117K 0.03% 513
2024
Q1 		$308K Buy
+7,186
New +$303K 0.02% 607

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's GPCR Position: Q3 2025 in Review

Virtu Financial sold out of Structure Therapeutics (GPCR) in Q3 2025, closing a stake of 14,779 shares — an estimated $307K sold.

Virtu Financial first reported a position in GPCR in Q1 2024 and held it in 3 quarters. The position peaked at $394K in Q2 2024. 156 funds tracked by Wall St. Rank hold GPCR as of Q3 2025.

  • Virtu Financial reported no remaining Structure Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 14,779 Structure Therapeutics shares in Q3 2025, an estimated $307K.
  • Virtu Financial first reported a position in Structure Therapeutics in Q1 2024 and held it in 3 quarters.
  • Virtu Financial's Structure Therapeutics position peaked at $394K in Q2 2024.
  • 156 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.